SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-20-000971
Filing Date
2020-11-13
Accepted
2020-11-13 16:52:21
Documents
8
Period of Report
2020-11-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opgen_8k.htm 8-K 19346
2 AMENDED AND RESTATED AT THE MARKET OFFERING AGREEMENT ex1x1.htm EX-1.1 253864
3 EXHIBIT 5.1 ex5x1.htm EX-5.1 7856
4 EXHIBIT 99.1 ex99x1.htm EX-99.1 11735
5 GRAPHIC image_002.jpg GRAPHIC 2121
6 GRAPHIC image_003.jpg GRAPHIC 3313
7 GRAPHIC image_004.jpg GRAPHIC 3662
8 GRAPHIC image_005.jpg GRAPHIC 3861
  Complete submission text file 0001079973-20-000971.txt   312376
Mailing Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878
Business Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 201312268
SIC: 8071 Services-Medical Laboratories